EAM
GILD icon

EdenTree Asset Management’s Gilead Sciences GILD Stock Holding History

EdenTree Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,750
Closed -$142K – 72
2023
Q4 		$142K Hold
1,750
– – 0.04% 71
2023
Q3 		$131K Hold
1,750
– – 0.05% 63
2023
Q2 		$135K Buy
+1,750
New +$140K 0.05% 73

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EdenTree Asset Management's GILD Position: Q1 2024 in Review

EdenTree Asset Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 1,750 shares — an estimated $142K sold.

EdenTree Asset Management first reported a position in GILD in Q2 2023 and held it in 3 quarters. The position peaked at $142K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • EdenTree Asset Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • EdenTree Asset Management sold 1,750 Gilead Sciences shares in Q1 2024, an estimated $142K.
  • EdenTree Asset Management first reported a position in Gilead Sciences in Q2 2023 and held it in 3 quarters.
  • EdenTree Asset Management's Gilead Sciences position peaked at $142K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on EdenTree Asset Management's 13F filing for Q1 2024, filed 15 May 2024.